Merit Medical Systems (MMSI) Stock: Buy, Sell, or Hold?

MMSI - Merit Medical Systems Inc

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
$91.40
0.00 (0.00%) ▲
5d: +2.04%
30d: +4.97%
90d: +22.98%
WAIT
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Oct 29, 2026 6d

Get Alerted When MMSI Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 MIXED SIGNALS: MMSI shows conflicting indicators. Wait for confirmation before entering.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$108.37
Based on 5.6% avg growth
INTRINSIC VALUE TODAY
$67.29
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 17.9x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: MMSI is currently trading at $91.40, which is considered extended relative to its 30-day fair value range of $85.51 to $89.31. From a valuation perspective, the stock is trading at a premium (Forward PE: 19.8) compared to its historical average (17.9). At these levels, the market is pricing in 3.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, MMSI is in a strong uptrend. The price is approaching resistance at $92.05. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: MMSI scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $101.64 (+11.2%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $85.51 - $89.31
Company Quality Score 51/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 27.1%

All Signals

  • BEARISH: Price extended above range
  • BEARISH: Weak technical setup (30/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading below Wall St target ($101.64)
  • NEUTRAL: Market pricing in 3.4% annual earnings growth - fairly valued
  • WARNING: Composite score 51/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $85.51 - $89.31
Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $83.94
Resistance Level $92.05
Current Trend Strong Uptrend
Technical data as of Oct 21, 2026

Fundamental Context

Forward P/E (Next Year Est.) 19.82
Wall Street Target $101.64 (+11.2%)
Revenue Growth (YoY) 9.5%
Earnings Growth (YoY) 20.4%
Profit Margin 9.2%
Valuation Premium vs History +3.4% premium
PE vs Historical 19.8 vs 17.9 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +3.4% (market-implied from PE analysis)
1-Year Target $94.51 (+3%)
2-Year Target $97.72 (+7%)
3-Year Target $101.04 (+11%)
3-Yr Target (if PE normalizes) (PE: 20→18) PE COMPRESSION $91.26 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 19.9, Growth: 7.2%) $112.79 (+23%)
Base: (SPY PE: 19.8, Growth: 7.2%) $112.56 (+23%)
Bear: (PE: 16.8, Growth: 7.2%) $95.68 (+5%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (38x PE), but valuation improves significantly next year (20x PE) as earnings recover.
Trailing PE: 37.52 | Current EPS (TTM): $2.43
Bull Case $190.34 (+108%)
Analyst growth 89.8%, PE expands to 41.3
Base Case $173.04 (+89%)
Market implied 89.8%, PE stable at 37.5
Bear Case $62.00 (-32%)
Severe decline -20.0%, PE contracts to 31.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: October 22, 2026 9:12 AM ET
Data refreshes hourly during market hours. Next update: 10:12 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for MMSI.

Create Free Account

Already have an account? Log In

Top Rated Medical Instruments & Supplies Stocks

Top-rated stocks in Medical Instruments & Supplies by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ISRG
Intuitive Surgical Inc
STRONG BUY
34 analysts
$479 41 HOLD
ALC
Alcon AG
STRONG BUY
27 analysts
$83 45 HOLD
RGEN
Repligen Corporation
STRONG BUY
22 analysts
$198 53 HOLD
WST
West Pharmaceutical Serv…
STRONG BUY
17 analysts
$413 37 SELL
STVN
Stevanato Group SpA
BUY
14 analysts
$24 67 BUY

More Analysis for MMSI

MMSI Technical Chart MMSI Price Prediction MMSI Earnings Date MMSI Investment Advisor MMSI Fair Price Analyzer MMSI Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals